ReShape Lifesciences (Formally known as EnteroMedics)

280 articles about ReShape Lifesciences (Formally known as EnteroMedics)

• ReShape Lifesciences Reports Preliminary Fourth Quarter and Full Year 2017 Revenue

  2/1/2018

  ReShape Lifesciences announced today preliminary revenue results for the fourth quarter and year ended December 31, 2017.

• ReShape Lifesciences Announces Stocking Order From Medical Supplier in Dubai

  12/13/2017

  This order, the second since Al Zawhari's initial stocking order in August 2017, is to support increased demand for the Reshape Integrated Dual Balloon System from a leading hospital customer's growing bariatric program in Dubai.

• ReShape Lifesciences Announces Coverage of ReShape Dual Balloon by Major Telecom Company

  12/4/2017

  ReShape Lifesciences announced today that their ReShape Integrated Dual Balloon technology has been granted employee coverage.

• ReShape Lifesciences Announces Third Quarter 2017 Financial Results

  11/15/2017

  ReShape Lifesciences today reported financial results for the three months ended September 30, 2017.

• ReShape Lifesciences Presents New Data on Obesity Technologies

  11/3/2017

  The presentation discussed 342 patients that were implanted with the ReShape Integrated Dual Balloon at a multicenter bariatric practice.

• ReShape Lifesciences to Host Third Quarter Conference Call on November 14, 2017

  11/1/2017

  ReShape Lifesciences today announced that it will host a conference call to discuss financial results for the third quarter of 2017 on Tuesday, November 14, 2017 at 1:30 PM Pacific Time.

• 

  EnteroMedics Wants a Fresh Start, Changes Name to ReShape Lifesciences

  10/23/2017

  The new name reflects the Company's expansion and growth into a full-scale provider of medical devices to address the continuum of care for obesity and its associated health conditions.
• 

  Weeks After Buying ReShape Medical for $38M, EnteroMedics Bags $61M

  10/19/2017

  EnteroMedics recently filed with the SEC that it had raised $61M in a new equity financing round. There were 13 anonymous investors.

• EnteroMedics Announces New Employee Inducement Option Grants

  10/13/2017

• EnteroMedics Announces Acquisition Of ReShape Medical

  10/3/2017

• EnteroMedics Begins Post-Approval Study For The Treatment Of Obesity With vBloc Therapy

  9/6/2017

• Study Concludes Vagal Nerve Blocking With EnteroMedics' Vbloc Therapy Is Cost-Effective

  8/29/2017

• EnteroMedics Announces First Veterans Choice Program Vbloc Implant At Medstar Health In Maryland

  8/21/2017

• EnteroMedics Announces Proposed Underwritten Public Offering

  8/11/2017

• EnteroMedics Announces Pricing Of $20 Million Underwritten Public Offering

  8/11/2017

• EnteroMedics Announces Second Quarter 2017 Financial Results

  8/8/2017

• EnteroMedics To Discuss Business Strategy And Financial Results For The Second Quarter Of 2017

  8/2/2017

• EnteroMedics Receives Approval for Gastric Vest System Clinical Study in Spain

  7/31/2017

• EnteroMedics Announces First Veterans Choice Program vBloc Implant For Obesity At Methodist Dallas Medical Center

  7/25/2017

• EnteroMedics Announces Receipt Of European Patent Certificate

  7/20/2017